This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.03% per year. These returns cover a period from January 1, 1988 through July 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Brown-Forman (BF.B) to Sell Finlandia Vodka to Coca-Cola HBC
by Zacks Equity Research
Brown-Forman (BF.B) enters a deal to sell the Finlandia vodka brand to Coca-Cola HBC, following the brand's bleak prospects post the exit of its Russia operations.
Here's Why Procter & Gamble (PG) is an Attractive Pick Now
by Zacks Equity Research
Procter & Gamble (PG) is a lucrative pick on its ongoing business momentum, strength across businesses, pricing actions and productivity plans.
Here's Why Brown-Forman (BF.B) is Marching Ahead of Its Industry
by Zacks Equity Research
Brown-Forman (BF.B) is poised for growth on solid brand demand, acquisitions, portfolio premiumization, product innovation and strategic relationships amid cost headwinds.
Zacks Investment Ideas feature highlights: Adobe, McDonalds, Pepsi and Procter and Gamble
by Zacks Equity Research
Adobe, McDonalds, Pepsi and Procter and Gamble are part of the Zacks Investment Ideas article.
Time to Buy These 4 Stocks with Multi-Decade Earnings Growth?
by Ethan Feller
Steady can sometimes be boring, but in investing, boring is profitable
Colgate (CL) Looks Solid on Pricing Action & Expansion Strategy
by Zacks Equity Research
Pricing actions, revenue management initiatives, innovation, brand strength and digital growth position Colgate (CL) for growth amid higher costs and currency headwinds.
Procter & Gamble Company (The) (PG) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
P&G (PG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
P&G (PG) Is Considered a Good Investment by Brokers: Is That True?
by Zacks Equity Research
The average brokerage recommendation (ABR) for P&G (PG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Procter & Gamble (PG) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Procter & Gamble (PG) closed at $145.06, marking a -0.24% move from the previous day.
Top Stock Reports for Procter & Gamble, Bank of America & Abbott Laboratories
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Company (PG), Bank of America Corporation (BAC) and Abbott Laboratories (ABT).
Brown-Forman (BF.B) Earnings Lag Q4 Estimates, Sales Beat
by Zacks Equity Research
Brown-Forman's (BF.B) Q4 results reflect gains from a robust top line on strength in its brands, premiumization and growth across regions. Input cost inflation acts as a deterrent.
Boston Beer (SAM) Relies on Growth Strategic Amid Cost Woes
by Zacks Equity Research
Pricing actions, product innovation and cost-saving efforts, along with the three-point growth plan, are likely to aid Boston Beer (SAM).
Molson Coors (TAP) Gains 13.8% in 3 Months Amid Inflation Woes
by Zacks Equity Research
Although rising inflation is concerning, brand strength, product innovation and a revitalization plan bode well for Molson Coors (TAP).
Should You Invest in the Consumer Staples Select Sector SPDR ETF (XLP)?
by Zacks Equity Research
Sector ETF report for XLP
Is It Worth Investing in P&G (PG) Based on Wall Street's Bullish Views?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), P&G (PG) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Procter & Gamble Company (The) (PG) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
P&G (PG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
4 Blue-Chip Stocks From a Struggling Dow for a Stable Portfolio
by Nalak Das
We have narrowed our search to four blue-Chip (components of Dow) stocks with strong potential for 2023. These are: MCD, WMT, CAT and PG.
Company News for May 23, 2023
by Zacks Equity Research
Companies in The News Are: GOOGL, PFE, NVO, CBRE, PG
5 Soaps & Cleaning Materials Stocks to Gain in a Prospering Industry
by Rajani Lohia
The soap and cleaning materials industry is positioned to gain from revived demand trends, pricing actions, innovation, digital transformation and brand building, while elevated costs remain headwinds. Players like PG, CL, RBGLY, CHD and CLX look well-poised.
2 Key Themes From the Q1 Earnings Season
by Derek Lewis
With earnings season winding down, it's beneficial to take a few steps back and reflect on a few key themes we've seen, as it can better prepare us for the coming cycle.
Is Lamb Weston (LW) Outperforming Other Consumer Staples Stocks This Year?
by Zacks Equity Research
Here is how Lamb Weston (LW) and Procter & Gamble (PG) have performed compared to their sector so far this year.
Procter & Gamble (PG) Up 11.5% in Three Months: Here's Why
by Zacks Equity Research
Although high costs and negative currency impacts remain near-term headwinds for Procter & Gamble (PG), robust pricing and productivity plans are likely to be beneficial.
Is It Worth Investing in P&G (PG) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for P&G (PG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Investors Heavily Search Procter & Gamble Company (The) (PG): Here is What You Need to Know
by Zacks Equity Research
P&G (PG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Here's Why You Should Invest in Clorox (CLX) Right Away
by Zacks Equity Research
Despite inflation concerns, Clorox (CLX) looks well-poised to drive growth in the future on the back of solid demand, pricing actions, cost-saving efforts and other growth strategies.